+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Africa Anticancer Drugs Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Dosage Form, Therapy, Sector, and Country

  • PDF Icon

    Report

  • 315 Pages
  • June 2025
  • Region: Africa
  • The Insight Partners
  • ID: 6102988
Description Jump to:
The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031.

The Africa anticancer drugs market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The increasing incidence of cancer and surging initiatives to improve cancer awareness are the key factors propelling the Africa anticancer drugs market growth.

Artificial Intelligence Accelerating Cancer Care
Artificial Intelligence (AI) is emerging as a transformative force in the anticancer drugs market, addressing critical challenges associated with genetic diversity, scarce clinical data, and limited access to personalized treatments. Amid the vast increase in cancer cases across the continent, AI is accelerating drug discovery, optimizing treatments, and fostering local innovation. The practical application of AI in cancer screening, diagnosis, and care opens the door for early cancer identification and accelerates the development of new treatment plans tailored to each patient.

Project Africa GRADIENT, a collaboration between the University of Cape Town, GlaxoSmithKline, Novartis, and the South African Medical Research Council, exemplifies AI's role in tailoring drugs to African genetic profiles. This initiative aims to enhance the efficacy of treatments designed for African populations by considering genetic variations that influence drug responses. This approach ensures that therapies are more effective and have fewer side effects, significantly improving patient outcomes. Additionally, AI accelerates the drug discovery process by analyzing vast amounts of biological data to identify potential drug candidates.

Companies such as Insilico Medicine employ AI-driven platforms to design small-molecule treatments and discover drug targets, reducing drug development timelines from years to months. This rapid development is crucial for addressing the increasing cancer burden in Africa, where early detection and treatment options are often limited. In April 2023, AstraZeneca (a global pharmaceutical company) joined forces with South African health-tech firm MedSol AI Solutions to advance the use of AI in breast cancer detection. Their collaboration centers around a cutting-edge Wi-Fi-enabled ultrasound probe capable of identifying breast cancer within seconds.

Their Melusi Breast AI rapid detection app will be deployed in rural clinics to support early diagnosis, particularly in underserved areas. A dedicated referral system backs the initiative to ensure that women with positive results can access timely therapeutic interventions. Thus, AI integration into the cancer care landscape in Africa would enhance treatment outcomes and promote self-reliance in medical research and development.

By harnessing AI, African nations can address the unique challenges posed by genetic diversity and limited access to personalized care, paving the way for more equitable healthcare solutions. Hence, by enabling personalized treatments, accelerating drug development, and fostering inclusive research, AI is setting new trends in the Africa anticancer drugs market.
  • Based on drug class, the Africa anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, hormonal drugs, immunotherapy drugs, gene therapy drugs, radiopharmaceuticals, and others. The cytotoxic drugs segment held the largest share in 2024. The targeted drugs segment is expected to register the highest CAGR during 2025-2031.
  • Based on indication, the Africa anticancer drugs market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, and others. The lung cancer segment held the largest market share in 2024, and the breast cancer segment is estimated to register the highest CAGR in the market during 2025-2031.
  • In terms of therapy type, the Africa anticancer drugs market is categorized into chemotherapy, targeted therapy, immunotherapy, gene therapy, radiopharmaceutical therapy, and others. The chemotherapy segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.
  • Based on dosage form, the Africa anticancer drugs market is categorized into tablet and capsule, injectable, and liquid. The tablet and capsule segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.
  • By sector, the market is bifurcated into public and private. The public segment held a larger share of the market in 2024. The private segment is estimated to register a higher CAGR during 2025-2031.
A few of the major primary and secondary sources referred to while preparing the report on the Africa anticancer drugs market are the GLOBOCAN - IARC, WHO Cancer Country Profiles, WHO Global Health Observatory, UN Comtrade Database, IAEA DIRAC, World Bank, WHO Global Health Expenditure Database, Ministries of Health (e.g., Egypt CAPA, Nigeria NHIS), African Medicines Agency (AMA), BMI Fitch).

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Africa anticancer drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Africa anticancer drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Africa anticancer drugs market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. African Anticancer Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Cancer Prevalence, By Country
4.4 Cancer Therapeutics: Pricing Analysis, 2024
4.5 Import-export Scenario in Africa
4.6 Ecosystem Analysis
4.6.1 List of Vendors in the Value Chain
5. African Anticancer Drugs Market - Key Market Dynamics
5.1 African Anticancer Drugs Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Cancer Incidence
5.2.2 Increasing Initiatives to Improve Cancer Awareness
5.3 Market Restraints
5.3.1 Unaffordability and Limited Availability of Cancer Drugs
5.4 Market Opportunities
5.4.1 Surging Number of Clinical Trials
5.5 Future Trends
5.5.1 Artificial Intelligence Accelerating Cancer Care
5.6 Impact of Drivers and Restraints:
6. African Anticancer Drugs Market - Global Market Analysis
6.1 African Anticancer Drugs Market Revenue (US$ Million), 2021-2031
6.2 African Anticancer Drugs Market Forecast Analysis
7. African Anticancer Drugs Market Analysis - by Drug Class Type
7.1 Cytotoxic Drugs
7.1.1 Overview
7.1.2 Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Targeted Drugs
7.2.1 Overview
7.2.2 Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Hormonal Drugs
7.3.1 Overview
7.3.2 Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Immunotherapy Drugs
7.4.1 Overview
7.4.2 Immunotherapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Gene Therapy Drugs
7.5.1 Overview
7.5.2 Gene Therapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Radiopharmaceuticals
7.6.1 Overview
7.6.2 Radiopharmaceuticals: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8. African Anticancer Drugs Market Analysis - by Indication
8.1 Lung Cancer
8.1.1 Overview
8.1.2 Lung Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Stomach Cancer
8.2.1 Overview
8.2.2 Stomach Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Colorectal Cancer
8.3.1 Overview
8.3.2 Colorectal Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Breast Cancer
8.4.1 Overview
8.4.2 Breast Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Prostrate Cancer
8.5.1 Overview
8.5.2 Prostrate Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9. African Anticancer Drugs Market Analysis - by Dosage Form
9.1 Tablet and Capsule
9.1.1 Overview
9.1.2 Tablet and Capsule: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Liquid
9.3.1 Overview
9.3.2 Liquid: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10. African Anticancer Drugs Market Analysis - by Therapy
10.1 Chemotherapy
10.1.1 Overview
10.1.2 Chemotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Targeted Therapy
10.2.1 Overview
10.2.2 Targeted Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Immunotherapy
10.3.1 Overview
10.3.2 Immunotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Gene Therapy
10.4.1 Overview
10.4.2 Gene Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Radiopharmaceutical Therapy
10.5.1 Overview
10.5.2 Radiopharmaceutical Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11. African Anticancer Drugs Market Analysis - by Sector
11.1 Private
11.1.1 Overview
11.1.2 Private: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Public
11.2.1 Overview
11.2.2 Public: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
12. African Anticancer Drugs Market - Geographical Analysis
12.1 Africa
12.1.1 African Anticancer Drugs Market Overview
12.1.2 African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.2.1 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Drug Class Type
12.1.2.2 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Cytotoxic Drugs
12.1.2.3 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Targeted Drugs
12.1.2.4 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Hormonal Drugs
12.1.2.5 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Indication
12.1.2.6 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Dosage Form
12.1.2.7 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Therapy
12.1.2.8 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Sector
12.1.3 African Anticancer Drugs Market - Revenue and Forecast Analysis - by Country
12.1.3.1 South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.1.1 South Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.1.2 South Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.1.3 South Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.1.4 South Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.1.5 South Africa: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.1.6 South Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.1.7 South Africa: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.1.8 South Africa: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.2 Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.2.1 Egypt: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.2.2 Egypt: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.2.3 Egypt: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.2.4 Egypt: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.2.5 Egypt: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.2.6 Egypt: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.2.7 Egypt: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.2.8 Egypt: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.3 Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.3.1 Algeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.3.2 Algeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.3.3 Algeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.3.4 Algeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.3.5 Algeria: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.3.6 Algeria: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.3.7 Algeria: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.3.8 Algeria: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.4 Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.4.1 Morocco: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.4.2 Morocco: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.4.3 Morocco: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.4.4 Morocco: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.4.5 Morocco: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.4.6 Morocco: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.4.7 Morocco: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.4.8 Morocco: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.5 Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.5.1 Tunisia: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.5.2 Tunisia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.5.3 Tunisia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.5.4 Tunisia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.5.5 Tunisia: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.5.6 Tunisia: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.5.7 Tunisia: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.5.8 Tunisia: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.6 Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.6.1 Nigeria: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.6.2 Nigeria: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.6.3 Nigeria: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.6.4 Nigeria: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.6.5 Nigeria: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.6.6 Nigeria: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.6.7 Nigeria: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.6.8 Nigeria: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.7 Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.7.1 Kenya: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.7.2 Kenya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.7.3 Kenya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.7.4 Kenya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.7.5 Kenya: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.7.6 Kenya: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.7.7 Kenya: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.7.8 Kenya: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.8 Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.8.1 Ethiopia: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.8.2 Ethiopia: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.8.3 Ethiopia: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.8.4 Ethiopia: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.8.5 Ethiopia: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.8.6 Ethiopia: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.8.7 Ethiopia: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.8.8 Ethiopia: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.9 Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.9.1 Ghana: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.9.2 Ghana: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.9.3 Ghana: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.9.4 Ghana: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.9.5 Ghana: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.9.6 Ghana: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.9.7 Ghana: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.9.8 Ghana: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.10 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.10.1 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.10.2 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.10.3 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.10.4 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.10.5 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Indication
12.1.3.10.6 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.10.7 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.10.8 Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market Breakdown, by Sector
12.1.3.11 Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.11.1 Senegal: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.11.2 Senegal: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.11.3 Senegal: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.11.4 Senegal: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.11.5 Senegal: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.11.6 Senegal: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.11.7 Senegal: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.11.8 Senegal: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.12 Libya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.12.1 Libya: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.12.2 Libya: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.12.3 Libya: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.12.4 Libya: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.12.5 Libya: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.12.6 Libya: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.12.7 Libya: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.12.8 Libya: African Anticancer Drugs Market Breakdown, by Sector
12.1.3.13 Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
12.1.3.13.1 Rest of Africa: African Anticancer Drugs Market Breakdown, by Drug Class Type
12.1.3.13.2 Rest of Africa: African Anticancer Drugs Market Breakdown, by Cytotoxic Drugs
12.1.3.13.3 Rest of Africa: African Anticancer Drugs Market Breakdown, by Targeted Drugs
12.1.3.13.4 Rest of Africa: African Anticancer Drugs Market Breakdown, by Hormonal Drugs
12.1.3.13.5 Rest of Africa: African Anticancer Drugs Market Breakdown, by Indication
12.1.3.13.6 Rest of Africa: African Anticancer Drugs Market Breakdown, by Dosage Form
12.1.3.13.7 Rest of Africa: African Anticancer Drugs Market Breakdown, by Therapy
12.1.3.13.8 Rest of Africa: African Anticancer Drugs Market Breakdown, by Sector
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Industry Landscape
14.1 Overview
14.2 Market Initiative
14.3 Partnerships and Collaborations
14.4 Other Developments
15. Company Profiles
15.1 Amgen Inc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Gilead Sciences Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Novartis AG
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 F. Hoffmann-La Roche Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 BeiGene Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Takeda Pharmaceutical Co Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 GSK Plc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Sanofi SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Cipla Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Johnson & Johnson
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Aspen Holdings
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Pfizer Inc
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 AstraZeneca Plc
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 Merck & Co Inc
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
15.15 Daiichi Sankyo Co Ltd
15.15.1 Key Facts
15.15.2 Business Description
15.15.3 Products and Services
15.15.4 Financial Overview
15.15.5 SWOT Analysis
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms
List of Tables
Table 1. African Anticancer Drugs Market Segmentation
Table 2. Methodology 1 - Africa Market
Table 3. Methodology 2 - Africa Market
Table 4. Each country’s market share is determined using five weighted parameters:
Table 5. Market Issues in African Anti-Cancer Drugs Market
Table 6. Cancer Prevalence, By Country- 2023
Table 7. Cancer Therapeutics, Pricing Analysis (Price (US$/Unit)- 2023
Table 8. Import Value and Quantity of Medicinal Products by Key African Countries (2024)
Table 9. Export Value and Quantity of Medicinal Products by Key African Countries (2024)
Table 10. List of Vendors
Table 11. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million)
Table 12. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million)
Table 13. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Table 14. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Table 15. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Table 16. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Table 17. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Table 18. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Table 19. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Drug Class Type
Table 20. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 21. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Cytotoxic Drugs
Table 22. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 23. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Targeted Drugs
Table 24. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 25. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Hormonal Drugs
Table 26. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 27. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Indication
Table 28. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 29. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Dosage Form
Table 30. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 31. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Therapy
Table 32. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 33. African Anticancer Drugs Market - Revenue, 2021 - 2024 (US$ Million) - by Sector
Table 34. African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 35. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 36. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 37. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 38. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 39. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 40. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 41. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 42. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 43. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 44. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 45. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 46. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 47. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 48. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 49. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 50. South Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 51. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 52. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 53. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 54. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 55. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 56. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 57. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 58. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 59. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 60. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 61. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 62. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 63. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 64. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 65. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 66. Egypt: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 67. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 68. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 69. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 70. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 71. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 72. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 73. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 74. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 75. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 76. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 77. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 78. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 79. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 80. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 81. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 82. Algeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 83. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 84. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 85. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 86. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 87. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 88. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 89. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 90. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 91. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 92. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 93. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 94. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 95. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 96. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 97. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 98. Morocco: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 99. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 100. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 101. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 102. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 103. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 104. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 105. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 106. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 107. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 108. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 109. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 110. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 111. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 112. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 113. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 114. Tunisia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 115. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 116. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 117. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 118. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 119. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 120. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 121. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 122. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 123. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 124. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 125. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 126. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 127. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 128. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 129. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 130. Nigeria: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 131. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 132. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 133. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 134. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 135. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 136. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 137. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 138. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 139. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 140. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 141. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 142. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 143. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 144. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 145. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 146. Kenya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 147. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 148. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 149. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 150. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 151. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 152. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 153. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 154. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 155. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 156. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 157. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 158. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 159. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 160. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 161. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 162. Ethiopia: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 163. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 164. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 165. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 166. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 167. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 168. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 169. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 170. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 171. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 172. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 173. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 174. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 175. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 176. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 177. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 178. Ghana: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 179. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 180. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 181. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 182. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 183. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 184. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 185. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 186. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 187. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 188. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 189. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 190. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 191. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 192. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 193. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 194. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 195. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 196. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 197. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 198. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 199. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 200. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 201. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 202. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 203. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 204. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 205. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 206. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 207. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 208. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 209. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 210. Senegal: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 211. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 212. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 213. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 214. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 215. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 216. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 217. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 218. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 219. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 220. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 221. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 222. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 223. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 224. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 225. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 226. Libya: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 227. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Drug Class Type
Table 228. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Drug Class Type
Table 229. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Cytotoxic Drugs
Table 230. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Cytotoxic Drugs
Table 231. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Targeted Drugs
Table 232. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Targeted Drugs
Table 233. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Hormonal Drugs
Table 234. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Hormonal Drugs
Table 235. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Indication
Table 236. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Indication
Table 237. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Dosage Form
Table 238. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Dosage Form
Table 239. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Therapy
Table 240. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Therapy
Table 241. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2024(US$ Million) - by Sector
Table 242. Rest of Africa: African Anticancer Drugs Market - Revenue, 2025 - 2031 (US$ Million) - by Sector
Table 243. Glossary of Terms, African Anticancer Drugs Market
List of Figures
Figure 1. African Anticancer Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Ecosystem Analysis
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. African Anticancer Drugs Market Revenue (US$ Million), 2021-2031
Figure 6. African Anticancer Drugs Market Share (%) - by Drug Class Type (2024 and 2031)
Figure 7. Cytotoxic Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Targeted Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Hormonal Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Immunotherapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Gene Therapy Drugs: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Radiopharmaceuticals: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. African Anticancer Drugs Market Share (%) - by Indication (2024 and 2031)
Figure 15. Lung Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Stomach Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Colorectal Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Breast Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Prostrate Cancer: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. African Anticancer Drugs Market Share (%) - by Dosage Form (2024 and 2031)
Figure 22. Tablet and Capsule: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Injectable: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Liquid: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. African Anticancer Drugs Market Share (%) - by Therapy (2024 and 2031)
Figure 26. Chemotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Targeted Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Immunotherapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Gene Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Radiopharmaceutical Therapy: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Others: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. African Anticancer Drugs Market Share (%) - by Sector (2024 and 2031)
Figure 33. Private: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 34. Public: African Anticancer Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 35. African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 36. African Anticancer Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. South Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 38. Egypt: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 39. Algeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 40. Morocco: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 41. Tunisia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 42. Nigeria: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 43. Kenya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 44. Ethiopia: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 45. Ghana: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 46. Cote d Ivoire (Ivory Coast): African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 47. Senegal: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 48. Libya: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 49. Rest of Africa: African Anticancer Drugs Market - Revenue, 2021 - 2031 (US$ Million)
Figure 50. Heat Map Analysis by Key Players
Figure 51. Company Positioning and Concentration

Companies Mentioned

Some of the leading companies in the Africa Anticancer Drugs Market include:
  • Amgen Inc
  • Gilead Sciences Inc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • BeiGene Ltd
  • Takeda Pharmaceutical Co Ltd
  • GSK Plc
  • Sanofi SA
  • Cipla Ltd
  • Johnson & Johnson
  • Aspen Holdings
  • Pfizer Inc
  • AstraZeneca Plc
  • Merck & Co Inc
  • Daiichi Sankyo Co Ltd

Table Information

Report AttributeDetails
No. of Pages315
PublishedJune 2025
Forecast Period2024 - 2031
Estimated Market Value ( USD ) in 2024 $ 1.81 Billion
Forecasted Market Value ( USD ) by 2031 $ 3.23 Billion
Compound Annual Growth Rate8.8%
Regions CoveredAfrica
No. of Companies Mentioned16

Related Topics

Related Reports

Anticancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Anticancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 247 Pages
  • Global
From
Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
African Plant-Based Products as a Source of Potent Drugs to Overcome Cancers and their Chemoresistance. Part 1. Cancer Chemoresistance, Screening Methods, and the Updated cut-off Points for the Classification of Natural Cytotoxic Products - Product Image

African Plant-Based Products as a Source of Potent Drugs to Overcome Cancers and their Chemoresistance. Part 1. Cancer Chemoresistance, Screening Methods, and the Updated cut-off Points for the Classification of Natural Cytotoxic Products

  • Book
  • Africa
Natural Products as Anticancer Agents - Product Image

Natural Products as Anticancer Agents

  • Book
Medicinal Chemistry of Chemotherapeutic Agents. A Comprehensive Resource of Anti-infective and Anti-cancer Drugs - Product Image

Medicinal Chemistry of Chemotherapeutic Agents. A Comprehensive Resource of Anti-infective and Anti-cancer Drugs

  • Book

About the Anticancer Agent Market

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.